Neoplasia (Tumor markers)

Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Neoplasia (Tumor markers).php on line 2
Neoplasia (Tumor markers)

LE WE PMID CA

Neoplasia (Tumor markers)

3037

Neubildung (Tumormarker)

Autoantibodies Anti Tumor associated Antigens

CNS (Neoplasia Neuroblastoma)

Colon and rectum (Neoplasia)

DNA (Measurement)

DNA (Methylation)

DNA (Repair and Toxicology)

DNA (Serum)

Fucose

Kidney (Neoplasm)

Lung and bronchial system (Neoplasia SCLC)

MUTYH

Neoplasia (Paraneoplastic syndromes)

Neoplasia (Tumor biology and immunology)

Neoplasia (Tumor markers)

OGG1

Ovary (Neoplasia)

Pleura (Effusion)

Prostate (Neoplasia)

RNA (MicroRNA)

Sialyl Lewis a

TMPRSS2

2000 1	Regular review: tumour markers in malignancies. [10669448] BMJ 320(7232): 424-7 (2000)
1972 2	Foetal antigens and their role in the diagnosis and clinical management of human neoplasms: a review. [4343676] Br J Cancer 26(5): 335-55 (1972)
1988 3	Tumor markers in cancer diagnosis and prognosis. [3127000] CA Cancer J Clin 38(2): 104-26 (1988)
2004 4	Identification of human tumor antigens and its implications for diagnosis and treatment of cancer. [15504244] Cancer Sci 95(10): 784-91 (2004)
2001 5	Serological markers for detection of cancer (Review). [11295120] Int J Mol Med 7(5): 547-56 (2001)
2008 6	Cancer-associated antigens and antigen arrays in serological diagnostics of malignant tumors. [18605981] Biochemistry (Mosc) 73(5): 562-72 (2008)
2007 7	Carbohydrate antigen sialyl Lewis a--its pathophysiological significance and induction mechanism in cancer progression. [17760270] Chang Gung Med J 30(3): 189-209 (2007)
2004 8	A systematic review of molecular and biological tumor markers in neuroblastoma. [14734444] Clin Cancer Res 10(1 Pt 1): 4-12 (2004)
2010 9	A review of the most promising biomarkers in colorectal cancer: one step closer to targeted therapy. [20584808] Oncologist 15(7): 699-731 (2010)
2005 10	Diagnostic value of CYFRA 21-1, CEA, CA 19-9, CA 15-3, and CA 125 assays in pleural effusions: analysis of 116 cases and review of the literature. [16079317] Oncologist 10(7): 501-7 (2005)
2010 11	Plasma cell-free DNA in ovarian cancer: an independent prognostic biomarker. [20166213] Cancer 116(8): 1918-25 (2010)
2009 12	Tissue biomarkers in renal cell carcinoma: issues and solutions. [19402057] Cancer 115(10 Suppl): 2290-7 (2009)
2002 13	Practice guidelines for tumor marker use in the clinic. [12142367] Clin Chem 48(8): 1151-9 (2002)
2010 14	National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in liver, bladder, cervical, and gastric cancers. [20207771] Clin Chem 56(6): e1-48 (2010)
2009 15	Serum tumor markers in oncology. [19432039] Isr Med Assoc J 11(2): 103-4 (2009)
2010 16	DNA methylation as a universal biomarker. [20465502] Expert Rev Mol Diagn 10(4): 481-8 (2010)
2010 17	Autoantibodies to tumor-associated antigens as diagnostic biomarkers in hepatocellular carcinoma and other solid tumors. [20370589] Expert Rev Mol Diagn 10(3): 321-8 (2010)
2007 18	Genomic tests: unreliable for cancer? A focus on circulating DNA and lung cancer. [18020899] Expert Rev Mol Diagn 7(6): 699-702 (2007)
2008 19	DNA repair of oxidative DNA damage in human carcinogenesis: potential application for cancer risk assessment and prevention. [18374480] Cancer Lett 266(1): 60-72 (2008)
2010 20	Passenger mutations as a marker of clonal cell lineages in emerging neoplasia. [20951806] Semin Cancer Biol 20(5): 294-303 (2010)
2009 21	Epigenetic alterations in human prostate cancers. [19520778] Endocrinology 150(9): 3991-4002 (2009)
2010 22	Serum fucose level in malignant diseases. [21131761] Indian J Cancer 47(4): 452-7 (2010)
2011 23	Small-cell lung cancer-associated autoantibodies: potential applications to cancer diagnosis, early detection, and therapy. [21450098] Mol Cancer 10(-): 33 (2011)
2010 24	Serum microRNAs as non-invasive biomarkers for cancer. [21110877] Mol Cancer 9(-): 306 (2010)
2011 25	Increased plasma concentrations of tumour markers in the absence of neoplasia. [21892908] Clin Chem Lab Med 49(10): 1605-20 (2011)
2009 26	Development and validation of a protein-based signature for the detection of ovarian cancer. [19389550] Clin Lab Med 29(1): 47-55 (2009)
2003 27	Tumor markers: from laboratory to clinical utility. [12813140] Mol Cell Proteomics 2(6): 378-87 (2003)
2008 28	DNA methylation in circulating tumour DNA as a biomarker for cancer. [19662228] Biomark Insights 2(-): 307-19 (2008)
2010 29	Systems approaches to molecular cancer diagnostics. [21189224] Discov Med 10(55): 531-42 (2010)
2010 30	Current status and future potential of somatic mutation testing from circulating free DNA in patients with solid tumours. [22132062] Hugo J 4(1-4): 11-21 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Neoplasia (Tumor markers).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Neoplasia (Tumor markers).php on line 92